Literature DB >> 16875676

A novel p53-binding domain in CUL7.

Jocelyn S Kasper1, Takehiro Arai, James A DeCaprio.   

Abstract

CUL7 is a member of the cullin RING ligase family and forms an SCF-like complex with SKP1 and FBXW8. CUL7 is required for normal mouse embryonic development and cellular proliferation, and is highly homologous to PARC, a p53-associated, parkin-like cytoplasmic protein. We determined that CUL7, in a manner similar to PARC, can bind directly to p53 but does not affect p53 expression. We identified a discrete, co-linear domain in CUL7 that is conserved in PARC and HERC2, and is necessary and sufficient for p53-binding. The presence of p53 stabilized expression of this domain and we demonstrate that this p53-binding domain of CUL7 contributes to the cytoplasmic localization of CUL7. The results support the model that p53 plays a role in regulation of CUL7 activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16875676     DOI: 10.1016/j.bbrc.2006.07.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization.

Authors:  Monica Cubillos-Rojas; Fabiola Amair-Pinedo; Roser Peiró-Jordán; Ramon Bartrons; Francesc Ventura; Jose Luis Rosa
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

2.  Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis.

Authors:  Xin-Hai Pei; Feng Bai; Zhijun Li; Matthew D Smith; Gabrielle Whitewolf; Ran Jin; Yue Xiong
Journal:  Cancer Res       Date:  2011-04-12       Impact factor: 12.701

3.  FBG1 is a promiscuous ubiquitin ligase that sequesters APC2 and causes S-phase arrest.

Authors:  Hsiang Wen; Namhun Kim; Ernesto J Fuentes; Adam Mallinger; Pedro Gonzalez-Alegre; Kevin A Glenn
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

4.  The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1.

Authors:  Dan Hanson; Philip G Murray; Amit Sud; Samia A Temtamy; Mona Aglan; Andrea Superti-Furga; Sue E Holder; Jill Urquhart; Emma Hilton; Forbes D C Manson; Peter Scambler; Graeme C M Black; Peter E Clayton
Journal:  Am J Hum Genet       Date:  2009-05-28       Impact factor: 11.025

Review 5.  Functional and pathological relevance of HERC family proteins: a decade later.

Authors:  Susana Sánchez-Tena; Monica Cubillos-Rojas; Taiane Schneider; Jose Luis Rosa
Journal:  Cell Mol Life Sci       Date:  2016-01-22       Impact factor: 9.261

6.  Induction of cullin 7 by DNA damage attenuates p53 function.

Authors:  Peter Jung; Berlinda Verdoodt; Aaron Bailey; John R Yates; Antje Menssen; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-22       Impact factor: 11.205

Review 7.  Cullin-RING E3 Ubiquitin Ligase 7 in Growth Control and Cancer.

Authors:  Zhen-Qiang Pan
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis.

Authors:  Joseph D Mancias; Laura Pontano Vaites; Sahar Nissim; Douglas E Biancur; Andrew J Kim; Xiaoxu Wang; Yu Liu; Wolfram Goessling; Alec C Kimmelman; J Wade Harper
Journal:  Elife       Date:  2015-10-05       Impact factor: 8.140

9.  Identifying biological pathways that underlie primordial short stature using network analysis.

Authors:  Dan Hanson; Adam Stevens; Philip G Murray; Graeme C M Black; Peter E Clayton
Journal:  J Mol Endocrinol       Date:  2014-04-07       Impact factor: 5.098

10.  Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2.

Authors:  Jesús García-Cano; Susana Sánchez-Tena; Joan Sala-Gaston; Agnès Figueras; Francesc Viñals; Ramon Bartrons; Francesc Ventura; Jose Luis Rosa
Journal:  Mol Oncol       Date:  2019-11-15       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.